The global softgel capsules market is expected to enjoy a valuation of US$ 1.1 Billion by the end of the year 2022, and further expand at a CAGR of 6.0% to reach a valuation of US$ 1.9 Billion by the year 2032. According to a recent study by Future Market Insights, gelatin softgel capsules are leading the market with a share of about 75.4% in the year 2021, within the global market.
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2021 | US$ 1.0 Billion |
Market Value 2022 | US$ 1.1 Billion |
Market Value 2032 | US$ 1.9 Billion |
CAGR 2022 to 2032 | 6.0% |
Market Share of Top 5 Countries | 55.0% |
Key Market Players | Aenova Group GmbH, Fuji Capsule Co., Ltd, Sirio Pharma Company Limited, Catalent, Inc, EuroCaps Ltd, Guangdong Yichao Biological Co., Ltd., Elnova Pharma, Captek Softgel International Inc, Hunan Er-Kang Pharmaceutical Co., Ltd, Soft Gel Technologies Inc., Patheon, United Labs, Curtis Health Caps, Procaps, and Delpharm Evreux |
Softgel capsules have a number of benefits over conventional oral solid dosage forms, and their acceptance as a dosage form is expanding for a number of reasons, including consumer preference. Softgel capsule dosage forms were developed to mask the unpleasant taste and odor of pharmaceuticals. Since soft gelatin capsules are self-lubricating, softgel capsules are simpler to swallow than tablets when taken with water.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for softgel capsules was approximately 35.5% of the overall US$ 3.1 Billion global gelatin capsules market in 2021.
The sale of softgel capsules expanded at a CAGR of 3.9% from 2012 to 2021, owing to the advent of the COVID-19 global pandemic and the associated global burden of disease.
Because of more exact compounding, blending, and dispensing of liquid fill ingredients, it is possible to offer an API with a better degree of accuracy and more consistency between various production lots. Since the entire encapsulation process can be completed inertly to safeguard pharmaceuticals against oxidation and degradation, soft gelatin capsule products often have superior stability.
The gelatin shell's tight seal shields the fill material from contamination by the air as well as the outside environment. In addition to visible light, the shell can be designed to block ultraviolet (UV) light. Additionally, softgel capsule formulation improves operator safety by reducing contamination caused by dust handling.
Softgel capsules (SGCs) appear more appealing and pleasurable to consumers as they can be produced in a variety of forms, sizes, and colors, as well as diverse drug delivery systems such as chewable softgels and meltable softgels.
Softgel capsule producers are increasing their product lines to offer a variety of vegan softgel capsules with improved attributes such as faster disintegration, increased gastric acid resistance, enteric coating, and specially developed capsules for clinical studies in order to maximize their revenue.
Thus, owing to the aforementioned factors, the global softgel capsules market is expected to grow at a CAGR of 6.0% during the forecast period from 2022 to 2032.
Vegetarian softgel capsules are produced by a number of different businesses and include pullulan, starch, and HPMC capsules. This could lead to increased product personalization in the pharmaceutical, cosmetic, and nutraceutical sectors, which could present profitable opportunities for the producers of softgel capsules.
However, some businesses continue to only offer hard and soft gelatin capsules in their product offering. If these companies add softgel capsules, vegetarian capsules, and other capsules made from plant-based gelatin to their product line, they can anticipate significant incremental growth prospects.
Companies are continuing to invest in technologies that provide alternatives to traditional drug delivery systems as the market for softgel products is still in its infancy.
Examples include imprinting the softgel ribbon before encapsulation with any appropriate logos or graphics. The ability to differentiate items through branding, a faster manufacturing process, and a lower risk of counterfeiting because of the label's uniform placement upon each capsule, are all advantages of labeling products before encapsulation. The process also ensures a higher level of quality control as it assists with the identification of fake products.
Thus, the introduction of new technologies to the market, such as the 3D printing of softgel capsules, will be a game-changer, and would further present the global market with lucrative opportunities for expansion.
SGC technology is thought to be relatively expensive to manufacture, which may raise consumer pricing. Many pharmaceutical businesses lack the specialized equipment necessary to fill SGCs, hence they generally rely on contract laboratories/manufacturers for supplies.
SGCs are susceptible to microbial infection and humidity, unlike solid dosage forms. If the medications are not kept in sealed containers or a cool, dry location, this could lead to problems with product stability.
Another issue with the adoption of soft gelatin capsule products is that some people have dietary restrictions that preclude them from eating animal products contained in SGCs. Gelatin is typically derived from pig and cow bones, skins, and other animal parts. Many vegetarians avoid using capsule shells since they are manufactured from animal tissues.
As a result, there are new innovations in animal-free gelatin capsules created from seaweed extract or other sources, although they are often more expensive and difficult to source.
Due to the abundance of providers for softgel capsule goods, the USA now has a market share of approximately 88.4% in North America and is predicted to maintain this growth over the projected period. The expansion of the product portfolios of the country's major players through increased R&D efforts would also help the USA market to flourish.
To increase their market share, manufacturers in the USA softgel capsules market are expanding their line of vegetarian softgel pills with improved qualities such as increased gastric acid resistance, quicker disintegration, enteric coating, and specially designed capsules for clinical trials.
For instance, various businesses produce different kinds of vegetarian supplements, like pullulan, starch, and HPMC capsules. In the nutraceutical, pharmaceutical, and cosmeceutical industries, this may result in greater product personalization and help drive up demand for softgel capsules, claims FMI.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Changsung, founded in 1972, has devoted itself to designing and manufacturing the greatest softgel encapsulation machines, making it the undisputed market leader in Korea and around the world.
All Changsung's machine products are not only certified for international quality standards such as ISO, CE, and UL, but they also comply with the manufacturing standards by cGMP and FDA, satisfying the requirements of a wide variety of customers all over the world.
The USA dominates the North American region with a total market share of about 88.4% in 2021 and is expected to continue to experience the same growth throughout the forecast period, owing to the presence of a large number of suppliers for softgel capsule products. Moreover, the increasing Research and Development activities by the established players in the country to expand their product portfolio will further propel the growth of the global softgel capsules market in the USA
Germany holds approximately 23.3% share of the European market in 2021 and is projected to display growth at a lucrative CAGR of 6.1% during the forecast period. The sales of softgel capsules in the country are supported by the high prevalence of chronic diseases, necessitating the production of nutrition supplements, as well as the presence of a vast geriatric population group susceptible to age-related deficiencies.
China is set to exhibit a CAGR of nearly 7.7% in the global softgel capsules market during the forecast period. With a high presence of contract manufacturing organizations, China holds a dominant share of around 7.9% within the global softgel capsules market. With growing awareness regarding health and personal care, the population group characterized as Gen Z in the country has propelled the demand for supplements and nutraceuticals, which combine traditional and herbal Chinese formulations. This has thus further enhanced the growth of the overall softgel capsules market in China.
The gelatin softgel capsule dosage form has a number of benefits over conventional oral dosage forms, including unit-dose solid dosage form delivery of a liquid matrix engineered to dissolve and enhance the oral bioavailability of a poorly soluble ingredient. Gelatin softgel capsules are expected to present high growth at a CAGR of 4.9% by the end of the forecast period, with a projected market share of about 67.6% in the global market in 2032.
Type-A gelatin (pork skin) holds a revenue share of 43.8% in 2021. Because of their superior strength, resistance to stress, capacity to hold water, higher melting point, faster production time, and low cost, porcine tissues are used to produce a vast majority of softgel capsules, resulting in a bigger market share for this sector.
Vitamin & Dietary Supplements hold a large global market share of about 31.1% in 2021. Softgel capsules improve bioavailability by providing nutrients in solutions or other absorption-enhancing mediums, and growing awareness about the use of health supplements has propelled this segment to be a major growth factor for overall market sales.
Contract manufacturing organizations hold the highest market share of 55.0% during the year 2021. Contract manufacturing is cost-effective and quality-focused practice. Manufacturing pharmaceuticals via a third party saves time, effort, and resources. It lowers labor costs and other expenses that a business must incur to manufacture softgel capsules.
Oral softgels lead the global market in terms of the route of administration, holding a market share of around 40.6% in 2021. Oral softgels are readily digested and disintegrate within a few minutes of entering the stomach. This ensures that the supplement or medication will not travel through the digestive system without being absorbed, increasing pharmacological efficacy and improving treatment outcomes.
There are numerous competitors in the softgel capsules industry, and the whole market is highly fragmented. To meet consumer demand and expand their clientele, these companies are using tactics including acquisitions and mergers partnerships and collaborations, and the introduction of new products.
Instances of key developmental strategies by the industry players in the softgel capsules market are given below:
Similarly, recent developments related to companies manufacturing softgel capsule products have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2012 to 2021 |
Historical Data Available for | 2022 to 2032 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, Israel, and South Africa |
Key Market Segments Covered | Product, Raw Material, Application, End User, Route of Administration, and Region |
Key Companies Profiled |
|
Pricing | Available upon Request |
Key players are developing the market by investing in research and development.
The challenge in the softgel capsules market is the high manufacturing cost.
The pharmaceutical industry is the key consumer of the softgel capsules market.
The industry is estimated to reach US$ 1.9 billion by 2032.
The market is expected to record a CAGR of 6.0% through 2032.
1. Executive Summary | Softgel Capsules Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Regulatory Scenario
4.2. Consumption Scenario
4.3. Key Strategies, By Manufacturers
4.4. Product Adoption / Usage Analysis, By Region
4.5. Product USPs / Features (Product Mapping)
4.6. PESTEL analysis
4.7. Porter’s analysis
4.8. Softgel Capsules: Flow Chart
4.9. Tablet in Softgel Capsules
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Life Expectancy Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Advancements In Manufacturing Technology
5.2.3. Introduction Of New Materials
5.2.4. Focus On Developing Non-gelatin-based Capsules
5.2.5. Technical Benefits For Manufacturers And Suppliers
5.2.6. Reduction In Animal Stock Waste
5.2.7. Strategic Collaborations Among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Raw Material
6.1.3. By Application
6.1.4. By End User
6.1.5. By Route of Administration
6.1.6. By Country
6.2. 2021 Market Scenario
7. Global Market Volume (Million Units) Analysis 2012 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Volume (Million Units) Analysis, 2012 to 2021
7.2. Current and Future Market Volume (Million Units) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Global Average Pricing Analysis Benchmark
8.2. Regional level Pricing Analysis by Product
8.3. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2021 and Forecast, 2022 to 2032
9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2021
9.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis By Product, 2012 to 2021
10.3. Current and Future Market Application (US$ Million) and Volume (Million Units) Analysis and Forecast By Product, 2022 to 2032
10.3.1. Gelatin Softgel Capsules
10.3.2. Vegetarian Softgel Capsules
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Raw Material
11.1. Introduction / Key Findings
11.2. Historical Market Application (US$ Million) Analysis, By Raw Material, 2012 to 2021
11.3. Current and Future Market Application (US$ Milion) Analysis and Forecast By Raw Material, 2022 to 2032
11.3.1. Type-A Gelatin (Pork Skin)
11.3.2. Type-B Gelatin (Animal Bones & Skin)
11.3.3. Fish Bone Gelatin
11.3.4. Cellulose Derivatives
11.3.5. Starch Material
11.4. Market Attractiveness Analysis By Raw Material
12. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Application
12.1. Introduction / Key Findings
12.2. Historical Market Application (US$ Million) Analysis, By Application, 2012 to 2021
12.3. Current and Future Market Application (US$ Million) Analysis Forecast By Application, 2022 to 2032
12.3.1. Antacid & Antiflatulent Preparations
12.3.2. Antianemic Preparations (Hematinic Preparations)
12.3.3. Anti-inflammatory Drugs
12.3.4. Antibiotic & Antibacterial Drugs
12.3.5. Cough & Cold Preparations
12.3.6. Cardiovascular Therapy Drugs
12.3.7. Health Supplements
12.3.8. Vitamin & Dietary Supplements
12.3.9. Other Therapeutic Applications
12.4. Market Attractiveness Analysis By Application
13. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By End User
13.1. Introduction / Key Findings
13.2. Historical Market Application (US$ Million) Analysis, By End User, 2012 to 2021
13.3. Current and Future Market Application (US$ Million) Analysis Forecast By End User, 2022 to 2032
13.3.1. In-house Manufacturing
13.3.1.1. Pharmaceutical Companies
13.3.1.2. Nutraceutical Companies
13.3.1.3. Cosmeceutical Companies
13.3.2. Contract Manufacturing Organizations
13.4. Market Attractiveness Analysis By End User
14. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Route of Administration
14.1. Introduction / Key Findings
14.2. Historical Market Application (US$ Million) Analysis, By Route of Administration, 2012 to 2021
14.3. Current and Future Market Application (US$ Million) Analysis Forecast By Route of Administration, 2022 to 2032
14.3.1. Oral Softgels
14.3.2. Suppositories
14.3.3. Pessaries
14.3.4. Twist off Softgels
14.3.5. Others
14.4. Market Attractiveness Analysis By Route of Administration
15. Global Market Analysis 2012 to 2021 and Forecast 2022 to 2032, By Region
15.1. Introduction
15.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis By Region, 2012 to 2021
15.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. East Asia
15.3.5. South Asia
15.3.6. Oceania
15.3.7. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region
16. North America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021
16.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
16.3.1. By Country
16.3.1.1. USA
16.3.1.2. Canada
16.3.2. By Product
16.3.3. By Raw Material
16.3.4. By Application
16.3.5. By End User
16.3.6. By Route of Administration
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Raw Material
16.4.4. By Application
16.4.5. By End User
16.4.6. By Route of Administration
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country-Level Analysis & Forecast
16.7.1. USA Market Analysis
16.7.1.1. .Introduction
16.7.1.2. Market Analysis and Forecast by Market Taxonomy
16.7.1.2.1. By Product
16.7.1.2.2. By Raw Material
16.7.1.2.3. By Application
16.7.1.2.4. By End User
16.7.1.2.5. By Route of Administration
16.7.2. Canada Market Analysis
16.7.2.1. Introduction
16.7.2.2. Market Analysis and Forecast by Market Taxonomy
16.7.2.2.1. By Product
16.7.2.2.2. By Raw Material
16.7.2.2.3. By Application
16.7.2.2.4. By End User
16.7.2.2.5. By Route of Administration
17. Latin America Market Analysis 2012 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021
17.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
17.3.1. By Country
17.3.1.1. Mexico
17.3.1.2. Brazil
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Product
17.3.3. By Raw Material
17.3.4. By Application
17.3.5. By End User
17.3.6. By Route of Administration
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Raw Material
17.4.4. By Application
17.4.5. By End User
17.4.6. By Route of Administration
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country-Level Analysis & Forecast
17.7.1. Mexico Analysis
17.7.1.1. Introduction
17.7.1.2. Market Analysis and Forecast by Market Taxonomy
17.7.1.2.1. By Product
17.7.1.2.2. By Raw Material
17.7.1.2.3. By Application
17.7.1.2.4. By End User
17.7.1.2.5. By Route of Administration
17.7.2. Brazil Analysis
17.7.2.1. Introduction
17.7.2.2. Market Analysis and Forecast by Market Taxonomy
17.7.2.2.1. By Product
17.7.2.2.2. By Raw Material
17.7.2.2.3. By Application
17.7.2.2.4. By End User
17.7.2.2.5. By Route of Administration
17.7.3. Argentina Analysis
17.7.3.1. Introduction
17.7.3.2. Market Analysis and Forecast by Market Taxonomy
17.7.3.2.1. By Product
17.7.3.2.2. By Raw Material
17.7.3.2.3. By Application
17.7.3.2.4. By End User
17.7.3.2.5. By Route of Administration
18. Europe Analysis 2012 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021
18.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. Italy
18.3.1.3. France
18.3.1.4. United Kingdom
18.3.1.5. Spain
18.3.1.6. BENELUX
18.3.1.7. Russia
18.3.1.8. Nordic Countries
18.3.1.9. Rest of Europe
18.3.2. By Product
18.3.3. By Raw Material
18.3.4. By Application
18.3.5. By End User
18.3.6. By Route of Administration
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Raw Material
18.4.4. By Application
18.4.5. By End User
18.4.6. By Route of Administration
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country-Level Analysis & Forecast
18.7.1. Germany Analysis
18.7.1.1. Introduction
18.7.1.2. Market Analysis and Forecast by Market Taxonomy
18.7.1.2.1. By Product
18.7.1.2.2. By Raw Material
18.7.1.2.3. By Application
18.7.1.2.4. By End User
18.7.1.2.5. By Route of Administration
18.7.2. Italy Analysis
18.7.2.1. Introduction
18.7.2.2. Market Analysis and Forecast by Market Taxonomy
18.7.2.2.1. B By Product
18.7.2.2.2. By Raw Material
18.7.2.2.3. By Application
18.7.2.2.4. By End User
18.7.2.2.5. By Route of Administration
18.7.3. France Analysis
18.7.3.1. Introduction
18.7.3.2. Market Analysis and Forecast by Market Taxonomy
18.7.3.2.1. By Product
18.7.3.2.2. By Raw Material
18.7.3.2.3. By Application
18.7.3.2.4. By End User
18.7.3.2.5. By Route of Administration
18.7.4. UK Market Analysis
18.7.4.1. Introduction
18.7.4.2. Market Analysis and Forecast by Market Taxonomy
18.7.4.2.1. By Product
18.7.4.2.2. By Raw Material
18.7.4.2.3. By Application
18.7.4.2.4. By End User
18.7.4.2.5. By Route of Administration
18.7.5. Spain Market Analysis
18.7.5.1. Introduction
18.7.5.2. Market Analysis and Forecast by Market Taxonomy
18.7.5.2.1. By Product
18.7.5.2.2. By Raw Material
18.7.5.2.3. By Application
18.7.5.2.4. By End User
18.7.5.2.5. By Route of Administration
18.7.6. BENELUX Market Analysis
18.7.6.1. Introduction
18.7.6.2. Market Analysis and Forecast by Market Taxonomy
18.7.6.2.1. By Product
18.7.6.2.2. By Raw Material
18.7.6.2.3. By Application
18.7.6.2.4. By End User
18.7.6.2.5. By Route of Administration
18.7.7. Russia Market Analysis
18.7.7.1. Introduction
18.7.7.2. Market Analysis and Forecast by Market Taxonomy
18.7.7.2.1. By Product
18.7.7.2.2. By Raw Material
18.7.7.2.3. By Application
18.7.7.2.4. By End User
18.7.7.2.5. By Route of Administration
18.7.8. Nordic Countries Market Analysis
18.7.8.1. Introduction
18.7.8.2. Market Analysis and Forecast by Market Taxonomy
18.7.8.2.1. By Product
18.7.8.2.2. By Raw Material
18.7.8.2.3. By Application
18.7.8.2.4. By End User
18.7.8.2.5. By Route of Administration
19. East Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
19.1. Introduction
19.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021
19.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Product
19.3.3. By Raw Material
19.3.4. By Application
19.3.5. By End User
19.3.6. By Route of Administration
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Raw Material
19.4.4. By Application
19.4.5. By End User
19.4.6. By Route of Administration
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Country-Level Analysis & Forecast
19.7.1. China Market Analysis
19.7.1.1. Introduction
19.7.1.2. Market Analysis and Forecast by Market Taxonomy
19.7.1.2.1. By Product
19.7.1.2.2. By Raw Material
19.7.1.2.3. By Application
19.7.1.2.4. By End User
19.7.1.2.5. By Route of Administration
19.7.2. Japan Market Analysis
19.7.2.1. Introduction
19.7.2.2. Market Analysis and Forecast by Market Taxonomy
19.7.2.2.1. By Product
19.7.2.2.2. By Raw Material
19.7.2.2.3. By Application
19.7.2.2.4. By End User
19.7.2.2.5. By Route of Administration
19.7.3. South Korea Market Analysis
19.7.3.1. Introduction
19.7.3.2. Market Analysis and Forecast by Market Taxonomy
19.7.3.2.1. By Product
19.7.3.2.2. By Raw Material
19.7.3.2.3. By Application
19.7.3.2.4. By End User
19.7.3.2.5. By Route of Administration
20. South Asia Market Analysis 2012 to 2021 and Forecast 2022 to 2032
20.1. Introduction
20.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021
20.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
20.3.1. By Country
20.3.1.1. India
20.3.1.2. Indonesia
20.3.1.3. Malaysia
20.3.1.4. Thailand
20.3.1.5. Rest of South Asia
20.3.2. By Product
20.3.3. By Raw Material
20.3.4. By Application
20.3.5. By End User
20.3.6. By Route of Administration
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Raw Material
20.4.4. By Application
20.4.5. By End User
20.4.6. By Route of Administration
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Country-Level Analysis & Forecast
20.7.1. India Market Analysis
20.7.1.1. Introduction
20.7.1.2. Market Analysis and Forecast by Market Taxonomy
20.7.1.2.1. By Product
20.7.1.2.2. By Raw Material
20.7.1.2.3. By Application
20.7.1.2.4. By End User
20.7.1.2.5. By Route of Administration
20.7.2. Indonesia Market Analysis
20.7.2.1. Introduction
20.7.2.2. Market Analysis and Forecast by Market Taxonomy
20.7.2.2.1. By Product
20.7.2.2.2. By Raw Material
20.7.2.2.3. By Application
20.7.2.2.4. By End User
20.7.2.2.5. By Route of Administration
20.7.3. Malaysia Market Analysis
20.7.3.1. Introduction
20.7.3.2. Market Analysis and Forecast by Market Taxonomy
20.7.3.2.1. By Product
20.7.3.2.2. By Raw Material
20.7.3.2.3. By Application
20.7.3.2.4. By End User
20.7.3.2.5. By Route of Administration
20.7.4. Thailand Market Analysis
20.7.4.1. Introduction
20.7.4.2. Market Analysis and Forecast by Market Taxonomy
20.7.4.2.1. By Product
20.7.4.2.2. By Raw Material
20.7.4.2.3. By Application
20.7.4.2.4. By End User
20.7.4.2.5. By Route of Administration
21. Oceania Market 2012 to 2021 and Forecast 2022 to 2032
21.1. Introduction
21.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021
21.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Product
21.3.3. By Raw Material
21.3.4. By Application
21.3.5. By End User
21.3.6. By Route of Administration
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Raw Material
21.4.4. By Application
21.4.5. By End User
21.4.6. By Route of Administration
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis
21.7. Country-Level Analysis & Forecast
21.7.1. Australia Market Analysis
21.7.1.1. Introduction
21.7.1.2. Market Analysis and Forecast by Market Taxonomy
21.7.1.2.1. By Product
21.7.1.2.2. By Raw Material
21.7.1.2.3. By Application
21.7.1.2.4. By End User
21.7.1.2.5. By Route of Administration
21.7.2. New Zealand Market Analysis
21.7.2.1. Introduction
21.7.2.2. Market Analysis and Forecast by Market Taxonomy
21.7.2.2.1. By Product
21.7.2.2.2. By Raw Material
21.7.2.2.3. By Application
21.7.2.2.4. By End User
21.7.2.2.5. By Route of Administration
22. Middle East and Africa (MEA) Market Analysis 2012 to 2021 and Forecast 2022 to 2032
22.1. Introduction
22.2. Historical Market Application (US$ Million) and Volume (Million Units) Analysis Trend Analysis By Market Taxonomy, 2012 to 2021
22.3. Current and Future Market Value (US$ Million) and Volume (Million Units) Projections, 2022 to 2032
22.3.1. By Country
22.3.1.1. GCC Countries
22.3.1.2. Turkey
22.3.1.3. Israel
22.3.1.4. South Africa
22.3.1.5. Rest of Middle East and Africa
22.3.2. By Product
22.3.3. By Raw Material
22.3.4. By Application
22.3.5. By End User
22.3.6. By Route of Administration
22.4. Market Attractiveness Analysis
22.4.1. By Country
22.4.2. By Product
22.4.3. By Raw Material
22.4.4. By Application
22.4.5. By End User
22.4.6. By Route of Administration
22.5. Market Trends
22.6. Drivers and Restraints - Impact Analysis
22.7. Country-Level Analysis & Forecast
22.7.1. GCC Countries Market Analysis
22.7.1.1. Introduction
22.7.1.2. Market Analysis and Forecast by Market Taxonomy
22.7.1.2.1. By Product
22.7.1.2.2. By Raw Material
22.7.1.2.3. By Application
22.7.1.2.4. By End User
22.7.1.2.5. By Route of Administration
22.7.2. Turkey Market Analysis
22.7.2.1. Introduction
22.7.2.2. Market Analysis and Forecast by Market Taxonomy
22.7.2.2.1. By Product
22.7.2.2.2. By Raw Material
22.7.2.2.3. By Application
22.7.2.2.4. By End User
22.7.2.2.5. By Route of Administration
22.7.3. Israel Market Analysis
22.7.3.1. Introduction
22.7.3.2. Market Analysis and Forecast by Market Taxonomy
22.7.3.2.1. By Product
22.7.3.2.2. By Raw Material
22.7.3.2.3. By Application
22.7.3.2.4. By End User
22.7.3.2.5. By Route of Administration
22.7.4. South Africa Market Analysis
22.7.4.1. Introduction
22.7.4.2. Market Analysis and Forecast by Market Taxonomy
22.7.4.2.1. By Product
22.7.4.2.2. By Raw Material
22.7.4.2.3. By Application
22.7.4.2.4. By End User
22.7.4.2.5. By Route of Administration
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive
24.3.1. Aenova Group GmbH
24.3.1.1. Overview
24.3.1.2. Product Portfolio
24.3.1.3. Profitability by Market Segments (Product/Channel/Region)
24.3.1.4. Sales Footprint
24.3.1.5. Key Financials
24.3.1.6. SWOT Analysis
24.3.1.7. Strategy Overview
24.3.2. Fuji Capsule Co., Ltd
24.3.2.1. Overview
24.3.2.2. Product Portfolio
24.3.2.3. Profitability by Market Segments (Product/Channel/Region)
24.3.2.4. Sales Footprint
24.3.2.5. Key Financials
24.3.2.6. SWOT Analysis
24.3.2.7. Strategy Overview
24.3.3. Sirio Pharma Company Limited
24.3.3.1. Overview
24.3.3.2. Product Portfolio
24.3.3.3. Profitability by Market Segments (Product/Channel/Region)
24.3.3.4. Sales Footprint
24.3.3.5. Key Financials
24.3.3.6. SWOT Analysis
24.3.3.7. Strategy Overview
24.3.4. Catalent, Inc
24.3.4.1. Overview
24.3.4.2. Product Portfolio
24.3.4.3. Profitability by Market Segments (Product/Channel/Region)
24.3.4.4. Sales Footprint
24.3.4.5. Key Financials
24.3.4.6. SWOT Analysis
24.3.4.7. Strategy Overview
24.3.5. EuroCaps Ltd
24.3.5.1. Overview
24.3.5.2. Product Portfolio
24.3.5.3. Profitability by Market Segments (Product/Channel/Region)
24.3.5.4. Sales Footprint
24.3.5.5. Key Financials
24.3.5.6. SWOT Analysis
24.3.5.7. Strategy Overview
24.3.6. Guangdong Yichao Biological Co., Ltd.
24.3.6.1. Overview
24.3.6.2. Product Portfolio
24.3.6.3. Profitability by Market Segments (Product/Channel/Region)
24.3.6.4. Sales Footprint
24.3.6.5. Key Financials
24.3.6.6. SWOT Analysis
24.3.6.7. Strategy Overview
24.3.7. Elnova Pharma
24.3.7.1. Overview
24.3.7.2. Product Portfolio
24.3.7.3. Profitability by Market Segments (Product/Channel/Region)
24.3.7.4. Sales Footprint
24.3.7.5. Key Financials
24.3.7.6. SWOT Analysis
24.3.7.7. Strategy Overview
24.3.8. Captek Softgel International Inc
24.3.8.1. Overview
24.3.8.2. Product Portfolio
24.3.8.3. Profitability by Market Segments (Product/Channel/Region)
24.3.8.4. Sales Footprint
24.3.8.5. Key Financials
24.3.8.6. SWOT Analysis
24.3.8.7. Strategy Overview
24.3.9. Hunan Er-Kang Pharmaceutical Co., Ltd
24.3.9.1. Overview
24.3.9.2. Product Portfolio
24.3.9.3. Profitability by Market Segments (Product/Channel/Region)
24.3.9.4. Sales Footprint
24.3.9.5. Key Financials
24.3.9.6. SWOT Analysis
24.3.9.7. Strategy Overview
24.3.10. Soft Gel Technologies Inc.
24.3.10.1. Overview
24.3.10.2. Product Portfolio
24.3.10.3. Profitability by Market Segments (Product/Channel/Region)
24.3.10.4. Sales Footprint
24.3.10.5. Key Financials
24.3.10.6. SWOT Analysis
24.3.10.7. Strategy Overview
24.3.11. Patheon
24.3.11.1. Overview
24.3.11.2. Product Portfolio
24.3.11.3. Profitability by Market Segments (Product/Channel/Region)
24.3.11.4. Sales Footprint
24.3.11.5. Key Financials
24.3.11.6. SWOT Analysis
24.3.11.7. Strategy Overview
24.3.12. United Labs
24.3.12.1. Overview
24.3.12.2. Product Portfolio
24.3.12.3. Profitability by Market Segments (Product/Channel/Region)
24.3.12.4. Sales Footprint
24.3.12.5. Key Financials
24.3.12.6. SWOT Analysis
24.3.12.7. Strategy Overview
24.3.13. Curtis Health Caps
24.3.13.1. Overview
24.3.13.2. Product Portfolio
24.3.13.3. Profitability by Market Segments (Product/Channel/Region)
24.3.13.4. Sales Footprint
24.3.13.5. Key Financials
24.3.13.6. SWOT Analysis
24.3.13.7. Strategy Overview
24.3.14. Delpharm Evreux
24.3.14.1. Overview
24.3.14.2. Product Portfolio
24.3.14.3. Profitability by Market Segments (Product/Channel/Region)
24.3.14.4. Sales Footprint
24.3.14.5. Key Financials
24.3.14.6. SWOT Analysis
24.3.14.7. Strategy Overview
24.3.15. Procaps Group
24.3.15.1. Overview
24.3.15.2. Product Portfolio
24.3.15.3. Profitability by Market Segments (Product/Channel/Region)
24.3.15.4. Sales Footprint
24.3.15.5. Key Financials
24.3.15.6. SWOT Analysis
24.3.15.7. Strategy Overview
25. Assumptions and Acronyms Used
26. Research Methodology
Explore Healthcare Insights
View Reports